Coenzymes are small, organic, non-protein molecules that support enzymes in catalyzing biochemical reactions. These essential molecules are typically derived from vitamins or other critical nutrients, underscoring their nutritional importance. Coenzymes are believed to have originated in early prebiotic metabolism, existing before enzymes, polymers, and molecular replication mechanisms emerged. This ancient origin implies that coenzymes were among the earliest biomolecules involved in facilitating chemical transformations in primitive life forms¹.

Coenzymes are not proteins but rather a specialized group of cofactors, non-protein molecules that aid enzymes. Their functional role is believed to have emerged when small organic molecules with coenzyme-like properties functioned as “holoribozymes,” binding to RNA fragments and facilitating the synthesis of macromolecular templates, such as RNA. The RNA world hypothesis offers valuable insights into how early metabolic pathways may have operated prior to the evolution of modern protein enzymes^1, 2.

Coenzymes enable enzymes to perform their vital roles in a wide range of biochemical processes essential for life. They serve as molecular tools that enzymes use to perform chemical transformations that would otherwise be impossible or inefficient. They generally bind to specific enzymes and play an active role in facilitating catalytic transformations³. Their small size allows for easy diffusion within cells, and their chemical versatility enables participation in diverse reactions.

Browse our full range of biochemical products

Relationship with enzymes

Some enzymes are naturally active without coenzymes, whereas others require a coenzyme for activation. This distinction reflects the evolutionary adaptation of enzymes to diverse metabolic needs and environmental conditions. Enzymes that are inactive in the absence of their coenzymes are termed apoenzymes, while the active complex formed upon binding to a coenzyme is called a holoenzyme. The reversible nature of this binding enables cells to dynamically regulate enzyme activity in response to metabolic demands⁴.

Coenzyme specificity

Coenzyme specificity refers to an enzyme’s capability to preferentially bind and utilize a specific coenzyme during catalysis. This specificity can be modified via targeted mutations at the coenzyme-binding site.

For example, the enzyme malate dehydrogenase (MDH) typically shows specificity for either nicotinamide adenine dinucleotide (NAD+) or nicotinamide adenine dinucleotide phosphate (NADP⁺), depending on the organism and the direction of the reaction. The Bacillus subtilis malate dehydrogenase (BsMDH) is also primarily NAD⁺-dependent^{5, 6}.

A notable mutant, BsMDH-T7, shows a significantly higher affinity for nicotinamide adenine dinucleotide phosphate (NADPH) than nicotinamide adenine dinucleotide (NADH), indicating a shift in coenzyme preference. This shift not only enhances the enzyme’s catalytic efficiency but also broadens its potential for industrial applications, such as in the efficient production of malate. Therefore, the coenzyme specificity of MDH is crucial for optimizing metabolic pathways and improving biotransformation efficiency⁶.

Coenzyme reusability

Coenzymes are frequently regenerated during enzymatic reactions, enabling their reuse without being expended. This reusability is crucial for efficient biochemical processes, as it ensures their participation in successive reaction cascades and facilitates continuous catalytic activity⁷.

A recent study developed an innovative artificial cascade-catalytic system to convert methanol into ethylene glycol. This system, which incorporates methanol dehydrogenase, glycolaldehyde synthase, and lactaldehyde–pyruvate oxidoreductase, efficiently reuses coenzymes to simplify the metabolic pathway⁸.

The system achieved a high ethylene glycol concentration within 48 hours by optimizing the ribosome-binding site (RBS), isopropyl β-D-1-thiogalactopyranoside induction, and methanol concentration, achieving a conversion rate of 58.92%. This breakthrough highlights the critical role of coenzyme reusability in driving biotransformation processes and paves the way for the industrial-scale production of ethylene glycol⁸.

Types of coenzymes

Coenzymes are derived from vitamin and non-vitamin sources alike, each playing a significant role in a variety of biological processes.

Vitamin-derived coenzymes

Vitamins play a vital role in the body’s production of coenzymes, with water-soluble B-complex vitamins being particularly essential for their synthesis. B vitamin-derived coenzymes are involved in numerous enzymatic processes that support cellular functions, including brain and nervous system activities.

Key B vitamin-derived coenzymes include:

• Thiamine pyrophosphate (TPP), derived from thiamine (B1).
• Flavoproteins (FAD; FMN), from riboflavin (B2).
• NAD and NADP, from niacin (B3).
• Coenzyme A (CoA), from pantothenic acid (B5).
• Pyridoxal 5’-phosphate (PLP), from vitamin B6.
• Methyltetrahydrofolate, from folic acid (B9).
• Methylcobalamin and 5’-deoxyadenosylcobalamin, from cobalamin (B12).
• Biotin(B7).

These coenzymes facilitate important biochemical reactions, ensuring precise metabolic and physiological function^9–11.

Although B-complexes are important sources of coenzymes, vitamin C (ascorbic acid) also serves as a cofactor for enzymes such as prolyl hydroxylase, which is essential for collagen synthesis¹².

The coenzyme A (CoA) assay kit (ab102504) is designed for easy and accurate measurement of CoA levels in a wide range of biological samples, with a quantitative range of 2.5-250 µM and a rapid 1-hour assay time. Suitable for plasma, serum, tissue extracts, and more, this kit ensures reliable and consistent results.

NADP coenzyme (ab146316), with a purity of ≥93%, is designed to support redox reactions by facilitating electron transport in various cytochrome P450 and oxidase/reductase systems. It can be stored under desiccating conditions for up to 12 months, making it a versatile coenzyme suitable for a broad range of research applications.

Non-vitamin coenzymes

Non-vitamin coenzymes, derived from sources such as nucleotides, microbial metabolites, and plant-derived compounds, are necessary for various physiological processes, including matter and energy transport, blood clotting, and metabolism. These include:

• Energy transduction (eg, ATP/ADP in phosphorylation reactions)¹³.
• Electron transfer (eg, quinones in respiratory chains)¹³.
• Group transfer (eg, S-adenosylmethionine [SAM] for methylation)¹⁴.
• Blood clotting (eg, calcium ions in coagulation cascades)¹⁵.

Key examples include:

• Adenosine phosphates (AMP, ADP, and ATP): Central to cellular energy currency.
• Coenzyme Q₁₀/ubiquinone (CoQ₁₀): Mitochondrial electron carrier¹⁶.
• Lipoic acid: Critical in oxidative decarboxylation¹⁷.
• Glutathione: Redox regulation and detoxification¹⁸.

Coenzymes vs. cofactors

Cofactors are non-protein chemical compounds required for the biological activity of an enzyme, broadly categorized into organic coenzymes and inorganic cofactors.

The key distinction lies in their chemical nature and origin, coenzymes (eg, NAD⁺, FAD, and CoA) are organic molecules, often derived from vitamins, that transiently bind to enzymes and participate directly in catalysis by transferring functional groups or electrons. In contrast, inorganic cofactors (eg, Mg²⁺, Zn²⁺, and Fe²⁺/Fe³⁺) are metal ions that stabilize enzyme structures and mediate redox reactions without being consumed.

For example, lactate dehydrogenase relies on the coenzyme NAD⁺ to shuttle hydride ions, while carbonic anhydrase depends on a zinc ion (inorganic cofactor) to catalyze CO₂ hydration. Some enzymes require both, pyruvate dehydrogenase uses thiamine pyrophosphate as a coenzyme and Mg²⁺ as a cofactor¹⁹.

Although coenzymes often undergo structural changes during catalysis, they are regenerated and reused, in contrast to cofactors, which typically assist enzymes in a more general manner. Coenzymes, therefore, serve as specialized molecular tools for specific biochemical transformations¹.

Mechanism of action

By binding to enzymes and acting as carriers of electrons and chemical groups, coenzymes are molecular shuttles operating precisely through orchestrated binding and release mechanisms that maximize metabolic efficiency. Their ability to recycle (eg, NAD⁺ ⇌ NADH) allows a small pool of molecules to drive countless reactions. This recyclability makes coenzymes extraordinarily efficient; a single NAD⁺ molecule can participate in thousands of oxidation–reduction cycles per minute in active metabolic tissues.

Enzymes often rely on non-protein molecules to help facilitate their biochemical functions, either through temporary or permanent binding to the enzyme active site. The choice between temporary and permanent binding reflects evolutionary optimization, transient interactions allow metabolic flexibility, whereas permanent attachments ensure constant catalytic readiness for essential reactions.

Temporary or permanent binding to the enzyme active site

Temporary binding, such as that between NAD⁺ and dehydrogenases, occurs through weaker interactions such as ionic or hydrogen bonds, facilitating the release of the coenzyme post-reaction. This reversibility is essential for metabolic regulation and pathway branching. In contrast, permanent binding involves stronger covalent bonds. An example of permanent binding is the prosthetic group FAD in succinate dehydrogenase, which remains covalently attached throughout catalysis. This enduring association is particularly crucial for enzymes embedded in membranes, such as those within the electron transport chain.

The binding capacity of coenzymes is crucial for an enzyme’s optimal structure and function. Through induced fit mechanisms, coenzyme binding often produces conformational changes in enzymes, aligning catalytic residues with substrates in a precise manner, thereby enhancing reaction specificity.

Facilitation of biochemical reactions by acting as carriers of electrons, hydrogen, and chemical groups

Coenzymes act as carriers of various chemical groups, eg, NAD⁺, which functions primarily as an electron carrier in oxidation-reduction reactions. Here, NAD⁺ accepts a hydrogen ion (H⁺) and two electrons from one substrate, becoming NADH. NADH then donates these electrons to a second substrate, returning to its original form, NAD⁺. This process allows NAD⁺ to transfer electrons from one substrate (which gets oxidized) to another (which becomes reduced), facilitating essential metabolic processes²⁰.

In addition to NAD⁺, many other coenzymes function as carriers for various chemical groups such as carbon dioxide (CO₂; via biotin), acyl groups (via CoA), and methyl groups (via SAM)²¹. These coenzymes, in conjunction with their respective enzymes, catalyze the transfer of specific chemical groups between substrates, thereby driving a range of essential biochemical pathways.

Importance in biochemical efficiency

In cellular respiration, coenzymes such as NAD⁺ and FAD act as electron carriers, forming NADH during glycolysis and both NADH and flavin adenine dinucleotide dihydrogen (FADH₂) during the Krebs cycle²². These molecules transport electrons to the electron transport chain, enabling efficient ATP production.

Similarly, NADP⁺ serves as an essential electron carrier in light-dependent reactions during photosynthesis. It accepts electrons and hydrogen ions generated by the splitting of water, forming NADPH. This NADPH then provides the reducing power required in the Calvin cycle to convert CO₂ into glucose and other carbohydrates, supporting energy storage and biosynthesis. The coordinated action of these coenzyme systems allows photosynthetic organisms to convert light energy into chemical energy with remarkable efficiency.

Role of coenzymes in metabolism

Coenzymes contribute significantly to energy production and the synthesis of specialized metabolites.

Cellular respiration

Various pathways such as glycolysis, the Krebs cycle, and the electron transport chain have the involvement of coenzymes. A detailed discussion of their involvement follows.

Glycolysis

Glycolysisis a fundamental metabolic pathway that generates energy in the form of ATP, even in the absence of oxygen. Throughout its 10-step process, various coenzymes are involved in facilitating the biochemical reactions that convert glucose into pyruvate, which can either enter the mitochondria for further ATP production or be reduced to lactate under anaerobic conditions. In glycolysis, coenzymes serve as carriers for electrons, protons, and chemical groups, facilitating the proper function of the enzymes involved in this pathway^{8, 23}.

One of the most vital coenzymes in glycolysis is NAD⁺, which participates in oxidation–reduction reactions. During the conversion of glyceraldehyde 3-phosphate (G3P) to 1,3-bisphosphoglycerate (1,3-BPG) in glycolysis, NAD⁺ accepts two electrons and H⁺ and is converted to NADH^{8, 23}.

This reaction is catalyzed by glyceraldehyde 3-phosphate dehydrogenase (GAPDH). In the presence of oxygen, the resulting NADH can later be used to generate ATP in oxidative phosphorylation. This step is essential for maintaining the redox balance within the cell and enabling efficient energy production.

Another vital role of coenzymes in glycolysis is the participation of ATP in substrate-level phosphorylation. Coenzymes facilitate the transfer of phosphate groups to substrates via two key reactions, leading to ATP production. In the first reaction, 1,3-bisphosphoglycerate (1,3-BPG) donates a phosphate group to ADP, forming ATP and 3-phosphoglycerate (3-PG). In the second reaction, phosphoenolpyruvate (PEP) transfers a phosphate group to ADP, generating ATP and pyruvate. These reactions do not require oxygen and are essential for the anaerobic production of ATP^{24, 25}.

Krebs cycle

The Krebs cycle, also known as the citric acid cycle or tricarboxylic acid (TCA) cycle, is central to cellular energy production. This cycle involves eight enzyme-catalyzed reactions in the mitochondrial matrix, where acetyl-CoA is converted into CO₂ and high-energy electron carriers such as NADH and FADH₂. Coenzymes play a crucial role in facilitating these reactions by transporting electrons, protons, and chemical groups, thereby assisting in the catalysis of several steps in the cycle.

CoA is an essential coenzyme in the Krebs cycle, particularly in the conversion of acetyl-CoA, which is derived from carbohydrates, fats, and proteins, into its active form. Acetyl-CoA enters the cycle by combining with oxaloacetate to form citrate in the first step, catalyzed by the enzyme citrate synthase. This highly exergonic reaction is vital for the initiation of the Krebs cycle²⁶.

As with glycolysis, NAD⁺ plays an important role in the oxidation reactions of the Krebs cycle. During the conversion of isocitrate to α-ketoglutarate, NAD⁺ is reduced to NADH by the enzyme isocitrate dehydrogenase. This reaction also releases CO₂ and H⁺. The NADH generated in this cycle is subsequently used in the electron transport chain to produce ATP, thus contributing significantly to energy production^{26, 27}.

FAD is another essential coenzyme in the Krebs cycle, specifically involved in the conversion of succinate to fumarate by the enzyme succinate dehydrogenase. In this reaction, FAD accepts electrons and is reduced to FADH₂, which then enters the electron transport chain to help generate ATP. This step is unique because it is the only reaction in the Krebs cycle that occurs in the inner mitochondrial membrane, directly linking the TCA cycle to the respiratory chain²⁸.

CoQ₁₀ is part of the mitochondrial electron transport chain and is indirectly involved in the Krebs cycle. It accepts electrons from both FADH₂ (produced during the succinate to fumarate conversion) and NADH (generated in several steps of the cycle). These electrons ultimately drive ATP production through oxidative phosphorylation.

The NADH and FADH₂ molecules produced in the Krebs cycle carry high-energy electrons to the electron transport chain, where they are oxidized. This oxidation process is coupled with ATP production via chemiosmosis, a process that requires oxygen. As a result, NAD+ and FAD must be regenerated to sustain the cycle^{26, 28}.

Electron transport chain

The electron transport chain in mitochondria relies on coenzymes to transfer electrons and generate ATP. NADH and FADH₂ donate electrons to the chain, with NADH initiating the process at complex I and FADH₂ at complex II. As electrons pass through these complexes, NADH is oxidized to NAD⁺, and FADH₂ is oxidized to FAD. These electron transfers release energy, which is used to pump H⁺ across the mitochondrial membrane, creating an electrochemical gradient²⁸.

CoQ₁₀ carries electrons between complexes I/II and III, with cytochrome c shuttling electrons from complex III to complex IV. Oxygen serves as the final electron acceptor at complex IV, where it combines with protons to form water²¹.

This electron transfer process drives proton pumping, which powers ATP synthase, ultimately generating ATP. Coenzymes such as NADH, FADH₂, coenzyme Q, and cytochrome c are vital for maintaining the flow of electrons and the establishment of the proton gradient, both of which are essential for efficient ATP production.

Other metabolic pathways

Coenzymes derived from B-complexes (B1–B9) are especially essential for the metabolism of lipids, proteins, and carbohydrates. They play key roles in both primary metabolism—encompassing protein, carbohydrate, lipid, and nucleic acid processes—and specialized metabolism, which includes the biosynthesis of terpenoids, alkaloids, and phenolics. These coenzymes may directly catalyze the formation of specialized metabolites or act indirectly by supporting the production of precursors or other coenzymes²⁹.

For example, NADPH, derived from vitamin B3, is essential for redox reactions in enzymes such as cytochrome P450s, which are involved in the biosynthesis of specialized metabolites. Vitamin B2 contributes coenzymes FAD and FMN, which facilitate electron transfer in enzymes such as alcohol dehydrogenases and cytochrome P450s. Vitamin B5-derived CoA carries acyl groups in specialized metabolic reactions, and vitamin B6-derived pyridoxal 5’-phosphate (PLP) is involved in amino acid biosynthesis, an indirect pathway contributing to the production of specialized metabolites^{29, 30}.

Vitamin B9 supports methyltransferase reactions, and vitamin B1 (thiamine diphosphate, TDP) is crucial for energy-generating reactions in photosynthesis and respiration. Additionally, TDP plays a role in the biosynthesis of isoprenoids, which are essential for plant pigments, phytohormones, and terpenoid defense compounds^{14, 31, 32}.

These coenzymes often interact with one another, creating interdependencies that influence both primary and specialized metabolic pathways. Moreover, coenzymes and their precursors can serve as substrates for specialized metabolites, further underscoring their importance in metabolic networks.

Health and medical significance of coenzymes

Because coenzymes are essential for facilitating the biochemical processes that sustain life and health, their defective functioning can disrupt critical metabolic pathways and bodily functions, leading to a variety of health complications.

Common deficiencies and impacts

Coenzyme deficiencies can present with symptoms such as fatigue and weakness, and may lead to more severe disorders, including pellagra, caused by a deficiency in niacin (vitamin B3), or beriberi, resulting from a lack of thiamine (vitamin B1), which is essential for the formation of thiamine pyrophosphate.

Pellagra

Pellagra is characterized by the classic triad of dermatitis, dementia, and diarrhea. Its symptoms include gastrointestinal disturbances such as nausea and diarrhea, photosensitive skin lesions, and neurological changes, including anxiety, confusion, and muscle weakness. If left untreated, pellagra can be fatal.

Historically, pellagra was prevalent in populations with limited access to niacin-rich foods, particularly in the Southern United States during the early 1900s, where corn was a primary dietary staple³³. However, corn contains niacin in a bound, nutritionally unavailable form (niacytin), which requires alkali treatment to become bioavailable³⁴. This limitation in niacin bioavailability contributed to the deficiency.

In addition to dietary insufficiency, niacin deficiency can result from genetic disorders such as Hartnup disease³⁵, malabsorptive conditions, and the use of certain medications, such as those in isoniazid therapy³⁶. Although pellagra has been largely eliminated in industrialized countries thanks to improved nutrition, certain populations remain at risk, including individuals with chronic alcoholism, malabsorptive diseases, and eating disorders such as anorexia nervosa.

Beriberi

Beriberi presents in two primary forms: dry and wet beriberi. Dry beriberi predominantly affects the nervous system, causing symmetrical peripheral neuropathy, muscle weakness, and sensory deficits, especially in the extremities. Wet beriberi, on the other hand, primarily impacts the cardiovascular system, leading to heart failure, edema, and fluid retention. Patients with wet beriberi often experience tachycardia and dilated cardiomyopathy³⁷.

A severe complication of thiamine deficiency is Wernicke’s encephalopathy, which is characterized by a triad of ocular abnormalities (nystagmus and ophthalmoplegia), gait disturbances, and confusion. In advanced stages, untreated thiamine deficiency can lead to memory loss, psychosis, and ultimately death³⁸.

Dietary sources of coenzymes

Good dietary sources of thiamine include peas, whole grains, nuts, bananas, and fortified cereals. Riboflavin can be found in dairy products, eggs, and mushrooms. Niacin is abundant in meat, fish, eggs, and wheat flour. Chicken, beef, liver, eggs, mushrooms, and avocados are rich in pantothenic acid. Vitamin B6 is present in pork, poultry, fish, peanuts, oats, and bananas³⁹.

CoQ₁₀ is most concentrated in meat, fish, nuts, and certain oils, with smaller amounts found in dairy products, vegetables, fruits, and cereals. A well-balanced diet incorporating these sources of both vitamin and non-vitamin coenzymes is essential for maintaining optimal cellular function and preventing a range of diseases⁴⁰.

Applications in medicine and biotechnology

Research has underscored the presence of CoQ₁₀ in cellular membranes and blood plasma, highlighting its potent antioxidant properties⁴¹.These functions are essential for the clinical applications of CoQ₁₀. Recent studies have also demonstrated the influence of CoQ₁₀ on gene expression, particularly in relation to cell signaling, metabolism, and transport.

CoQ₁₀ deficiencies can arise from various factors, including genetic mutations, mitochondrial diseases, age-related oxidative stress, cancer, and as a side effect of statin medications⁴². Low levels of CoQ₁₀ have been associated with numerous conditions, including neurodegenerative disorders, diabetes, cancer, fibromyalgia, and cardiovascular diseases^{42, 43}.

CoQ₁₀ supplementation is generally safe and does not typically cause serious adverse effects. New formulations have improved absorption and tissue distribution of CoQ­₁₀, enhancing its effectiveness for mitochondrial energy deficiencies and antioxidant support, often providing significant symptomatic relief⁴⁴.

The protein engineering of oxidoreductases making use of nicotinamide-based coenzymes has significantly advanced synthetic biology applications. Coenzymes such as NAD and NADP are critical for most oxidoreductases, playing key roles in both catabolic and anabolic processes. The inherent preference of these enzymes for one coenzyme over another, depending on their metabolic function, can result in imbalances that hinder the efficiency of synthetic biology pathways⁴⁵.

To address these challenges, engineering the coenzyme preference of NAD(P)-dependent oxidoreductases has become a focus, particularly for large-scale industrial applications in synthetic biology. Cutting-edge engineering techniques, including rational design, semi-rational design, random mutagenesis, and directed evolution, combined with high-throughput screening, are being used to optimize the coenzyme preference of these enzymes. Furthermore, next-generation biomimetic nicotinamide-based coenzymes have been developed as alternatives to natural coenzymes, offering improved stability and cost-effectiveness.

Future perspectives on coenzymes

Coenzymes will continue to play a critical role in advancing health and longevity by supporting essential metabolic and antioxidant processes.

Maintaining CoQ₁₀ homeostasis through dietary supplementation and other pro-longevity interventions can help mitigate age-related mitochondrial dysfunction and oxidative damage, contributing to healthier aging. Emerging research indicates that NAD⁺ precursors, such as NMN and NR, activate sirtuins and enhance genomic stability, providing promising anti-aging strategies⁴⁶.Furthermore, CoQ₁₀ supplementation has shown considerable potential in improving glycemic control and reducing risks associated with hyperglycemia-related conditions⁴⁷.

Innovative therapies targeting coenzyme activity focus on modulating key metabolic pathways, such as those involving acetyl-CoA, to disrupt cancer progression and improve treatment outcomes. These strategies aim to reduce tumor growth and address metabolic reprogramming in cancer cells by inhibiting dysregulated enzymes such as ATP citrate lyase and acetyl-CoA synthetase⁴⁸.

Preclinical evidence supports the efficacy of pharmacological agents, including statins and enzyme inhibitors, in modulating acetyl-CoA metabolism. Additional therapeutic strategies focus on the selective depletion of coenzymes, such as NADPH and glutathione, thereby disrupting redox homeostasis in cancer cells and exacerbating oxidative stress. Notably, dual-targeting approaches that combine NADPH depletion with PARP inhibition have shown synergistic anti-tumor effects⁴⁹.

Furthermore, advanced nanocarriers, such as sorafenib-loaded frameworks with polyphenol coatings, have shown potential in targeting hypoxic tumor microenvironments. These systems induce apoptosis by depleting coenzymes and generating reactive oxygen species⁵⁰.

Conclusion

From their origins as prebiotic catalysts to their contemporary functions in health and disease, coenzymes exhibit significant evolutionary conservation and functional versatility, highlighting their role as essential molecular partners in the biochemical processes that sustain life. The dynamic interaction between enzymes and coenzymes, illustrated by the apoenzyme-holoenzyme transition, enables precise control over metabolic flux, with coenzyme specificity and reusability ensuring both efficiency and regulatory complexity.

Vitamin-derived coenzymes, such as NAD⁺ and FADH₂, are integral to maintaining redox balance, and non-vitamin cofactors, including ATP and CoQ₁₀, regulate energy metabolism and electron transport. Clinically, deficiencies in coenzymes result in severe nutritional disorders like pellagra and beriberi, underscoring their physiological importance. Moreover, therapeutic modulation of coenzyme pathways holds promise for interventions in aging and cancer treatment.

Emerging biotechnological applications are increasingly using engineered coenzyme specificity in industrial biocatalysis, with techniques such as directed evolution enhancing metabolic engineering, exemplified by the development of enzyme mutants such as BsMDH-T7. The advent of advanced delivery systems, such as NAD⁺ precursors and CoQ₁₀ nanocarriers, further underscores the translational potential of coenzymes in mitochondrial medicine.

As research advances, the roles of coenzymes in epigenetics—such as SAM-dependent methylation, and cell signaling, such as NAD⁺-dependent sirtuins—are becoming clearer. These coenzymes are now recognized as both metabolic intermediaries and therapeutic targets. Future innovations will likely harness coenzyme biochemistry for precision nutrition, synthetic biology, and targeted therapies, particularly in the context of age-related diseases where mitochondrial coenzyme metabolism is impaired. Therefore, coenzymes occupy a paramount position at the intersection of fundamental biochemistry and applied medicine, offering invaluable insights into the molecular mechanisms of life and potential solutions to pressing health challenges.

FAQs

How do coenzymes contribute to the efficiency of enzyme reactions?

Coenzymes enhance the efficiency of enzyme reactions by acting as carriers of chemical groups, electrons, and atoms, facilitating substrate transformation into products. They enable enzymes to lower activation energy and stabilize transition states, significantly accelerating reaction rates without being consumed in the process.

What are some common examples of coenzymes in cellular respiration?

Common coenzymes in cellular respiration include NAD⁺ and FAD, which act as electron carriers; coenzyme A (CoA) for acetyl group transfer; coenzyme Q₁₀ (ubiquinone) for electron transport in the electron transport chain; and thiamine pyrophosphate for decarboxylation in the pyruvate dehydrogenase complex. These coenzymes are essential for efficient ATP production.

How do coenzymes facilitate redox reactions?

Coenzymes facilitate redox reactions by acting as electron carriers, transferring electrons and hydrogen atoms between molecules to drive oxidation and reduction processes. For example, NAD⁺ and FAD accept electrons during metabolic reactions to form NADH and FADH₂, which then donate these electrons in pathways such as the electron transport chain, enabling energy production.

1. References

2. Kirschning, A. Coenzymes and Their Role in the Evolution of Life. Angew Chem Int Ed. 60, 6242–6269 (2021).
3. Sharov, A. A. Coenzyme world model of the origin of life. Biosystems. 144, 8–17 (2016).
4. Onkar, R. Coenzymes and Cofactors: Essential Partners in Enzymatic Catalysis. (No publication details available).
5. Baumann, C. A. & Stare, F. J. COENZYMES. Physiological Reviews. 19, 353–388 (1939).
6. Li, Y., Ogola, H. J. O. & Sawa, Y. l-Aspartate dehydrogenase: features and applications. Appl Microbiol Biotechnol. 93, 503–516 (2012).
7. Ge, Y.-D. et al. Enzymatic Characterization and Coenzyme Specificity Conversion of a Novel Dimeric Malate Dehydrogenase from Bacillus subtilis. Protein J. 42, 14–23 (2023).
8. Campbell, J. & Swi Chang, T. M. Enzymatic recycling of coenzymes by a multi-enzyme system immobilized within semipermeable collodion microcapsules. Biochimica et Biophysica Acta (BBA) - Enzymology. 397, 101–109 (1975).
9. Zhu, Z. et al. Constructing a New Pathway for Ethylene Glycol Biosynthesis and Its Coenzyme Reuse Mechanism. Fermentation. 10, 558 (2024).
10. Evers, M. S. et al. Vitamins in wine: Which, what for, and how much? Comp Rev Food Sci Food Safe. 20, 2991–3035 (2021).
11. Tarracchini, C. et al. Vitamin biosynthesis in the gut: interplay between mammalian host and its resident microbiota. Microbiol Mol Biol Rev. e00184-23 (2025). doi:10.1128/mmbr.00184-23.
12. Calogiuri, G. Hypersensitivity to Vitamins. Bentham Science Publishers. (2021). doi:10.2174/97816810889211210101.
13. Godoy-Parejo, C., Deng, C., Zhang, Y., Liu, W. & Chen, G. Roles of vitamins in stem cells. Cell. Mol. Life Sci. 77, 1771–1791 (2020).
14. Thapa, M. & Dallmann, G. Role of coenzymes in cancer metabolism. Seminars in Cell & Developmental Biology. 98, 44–53 (2020).
15. Rébeillé, F. et al. Roles of vitamins B5, B8, B9, B12 and molybdenum cofactor at cellular and organismal levels. Nat. Prod. Rep. 24, 949 (2007).
16. Seegers, W. H. Basic Enzymology of Blood Coagulation. Thromb Haemost. 14, 213–228 (1965).
17. Crane, F. L. The coenzyme q group (ubiquinones). Progress in the Chemistry of Fats and other Lipids. 7, 267–289 (1964).
18. Aszalos, A. A. Enzyme Cofactors. in Enzymes in Anesthesiology (ed. Foldes, F. F.) 53–65 (Springer New York, New York, NY, 1978). doi:10.1007/978-1-4612-6248-0_5.
19. Racker, E. Glutathione as a Coenzyme in Intermediary Metabolism. in Glutathione 165–183 (Elsevier, 1954). doi:10.1016/B978-1-4832-2900-3.50020-1.
20. Le, M. & Means, G. E. NAD+/NADH recycling by coimmobilized lactate dehydrogenase and glutamate dehydrogenase. Enzyme and Microbial Technology. 23, 49–57 (1998).
21. Oppenheimer, N. J. & Handlon, A. L. Mechanism of NAD-Dependent Enzymes. in The Enzymes. 20, 453–505 (Elsevier, 1992).
22. Palmieri, F., Monné, M., Fiermonte, G. & Palmieri, L. Mitochondrial transport and metabolism of the vitamin B‐derived cofactors thiamine pyrophosphate, coenzyme A, FAD and NAD+, and related diseases: A review. IUBMB Life. 74, 592–617 (2022).
23. Yan, L.-J., Wu, J., Jin, Z. & Zheng, H. Sources and implications of NADH/NAD+ redox imbalance in diabetes and its complications. DMSO. 145 (2016). doi:10.2147/DMSO.S106087.
24. Suchy, L. & Rudroff, F. Multi-Enzymatic Cascades In Vivo. in Enzyme Cascade Design and Modelling (eds. Kara, S. & Rudroff, F.) 49–63 (Springer International Publishing, Cham, 2021). doi:10.1007/978-3-030-65718-5_4.
25. Yang, B. et al. Construction of the Glycolysis Metabolic Pathway Inside an Artificial Cell for the Synthesis of Amino Acid and Its Reversible Deformation. J. Am. Chem. Soc. 146, 21847–21858 (2024).
26. Zhang, L. et al. Novel Structures of Type 1 Glyceraldehyde-3-phosphate Dehydrogenase from Escherichia coli Provide New Insights into the Mechanism of Generation of 1,3-Bisphosphoglyceric Acid. Biomolecules. 11, 1565 (2021).
27. Veech, R. L. et al. The “great” controlling nucleotide coenzymes. IUBMB Life. 71, 565–579 (2019).
28. Halestrap, A. P. & Brosnan, J. T. From metabolic cycles to compartmentation: another first for Krebs. Biochem. J. 524 (2008). doi:10.1042/BJ20080524.
29. Arneth, B. M. The Impact of Krebs Cycle Intermediates on the Endocrine System and Immune System: A Comparison. Endocrines. 4, 179–193 (2023).
30. Da Fonseca‐Pereira, P., Monteiro‐Batista, R. D. C., Araújo, W. L. & Nunes‐Nesi, A. Harnessing enzyme cofactors and plant metabolism: an essential partnership. The Plant Journal. 114, 1014–1036 (2023).
31. Walsh, C. T. Biologically generated carbon dioxide: nature’s versatile chemical strategies for carboxy lyases. Nat. Prod. Rep. 37, 100–135 (2020).
32. Bettendorff, L. The Chemistry, Biochemistry and Metabolism of Thiamin (Vitamin B1). in Food and Nutritional Components in Focus (ed. Preedy, V. R.) 71–92 (Royal Society of Chemistry, Cambridge, 2012). doi:10.1039/9781849734714-00071.
33. Maupin-Furlow, J. A. Vitamin B1 (Thiamine) Metabolism and Regulation in Archaea. in B Group Vitamins - Current Uses and Perspectives (eds. LeBlanc, J. G. & Giori, G. S. D.) (InTech, 2018). doi:10.5772/intechopen.77170.
34. Berdanier, C. D. Corn, Niacin, and the History of Pellagra. Nutr Today. 54, 283–288 (2019).
35. Van Arnum, S. D. Niacin, Nicotinamide, and Nicotinic Acid. in Kirk-Othmer Encyclopedia of Chemical Technology (ed. Kirk-Othmer) (Wiley, 2000). doi:10.1002/0471238961.1409010301181421.a01.
36. Clayton, P. T. et al. Pellagra with colitis due to a defect in tryptophan metabolism. Eur J Pediatr. 150, 498–502 (1991).
37. Prabhu, D., Dawe, R. S. & Mponda, K. Pellagra a review exploring causes and mechanisms, including isoniazid‐induced pellagra. Photoderm Photoimm Photomed. 37, 99–104 (2021).
38. Davidson, J. N. Recent Advances in the Biochemistry of the Vitamin B Complex and their Clinical Importance. Postgraduate Medical Journal. 15, 236–243 (1939).
39. Prensky, A. L. Wernicke Encephalopathy in Infants. Journal of Neuro-Ophthalmology. 25, 167–168 (2005).
40. Hoque, M. A Review on Different Dietary Sources of Important Vitamins and Electrolytes. Int. J. Res. Publ. Rev. 4, 731–736 (2023).
41. Pravst, I., Žmitek, K. & Žmitek, J. Coenzyme Q10 Contents in Foods and Fortification Strategies. Critical Reviews in Food Science and Nutrition. 50, 269–280 (2010).
42. Littarru, G. P. & Tiano, L. Bioenergetic and Antioxidant Properties of Coenzyme Q10: Recent Developments. Mol Biotechnol. 37, 31–37 (2007).
43. Potgieter, M., Pretorius, E. & Pepper, M. S. Primary and secondary coenzyme Q10 deficiency: the role of therapeutic supplementation. Nutr Rev. 71, 180–188 (2013).
44. Littarru, G. P. & Langsjoen, P. Coenzyme Q10 and statins: Biochemical and clinical implications. Mitochondrion. 7, S168–S174 (2007).
45. Barakat, A., Shegokar, R., Dittgen, M. & Müller, R. H. Coenzyme Q10 oral bioavailability: effect of formulation type. Journal of Pharmaceutical Investigation. 43, 431–451 (2013).
46. Chánique, A. M. & Parra, L. P. Protein Engineering for Nicotinamide Coenzyme Specificity in Oxidoreductases: Attempts and Challenges. Front. Microbiol. 9, 194 (2018).
47. Bonkowski, M. S. & Sinclair, D. A. Slowing ageing by design: the rise of NAD+ and sirtuin-activating compounds. Nat Rev Mol Cell Biol. 17, 679–690 (2016).
48. Liang, Y. et al. Effects of coenzyme Q10 supplementation on glycemic control: A GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials. eClinicalMedicine. 52, 101602 (2022).
49. Icard, P. et al. ATP citrate lyase: A central metabolic enzyme in cancer. Cancer Letters. 471, 125–134 (2020).
50. Li, Y. et al. Targeting NAD Metabolism: Rational Design, Synthesis and In Vitro Evaluation of NAMPT/PARP1 Dual-Target Inhibitors as Anti-Breast Cancer Agents. Molecules. 29, 2836 (2024).
51. Wang, L., Chen, M., Ran, X., Tang, H. & Cao, D. Sorafenib-Based Drug Delivery Systems: Applications and Perspectives. Polymers. 15, 2638 (2023).